Across European nations, the administration of ketamine for psychiatric conditions is experiencing a noticeable rise. First employed as an anesthetic, ketamine's potential as a therapy for depression , particularly severe forms, has fueled considerable exploration among healthcare providers. While protocols vary significantly from state to count